www.fdanews.com/articles/198345-ethicons-ablation-system-gets-breakthrough-designation
Ethicon’s Ablation System Gets Breakthrough Designation
August 4, 2020
The FDA has granted Johnson & Johnson subsidiary Ethicon a Breakthrough Device designation for its transbronchial microwave ablation technology with robotic-assisted bronchoscopy.
The designation pairs the NeuWave microwave ablation system with Auris Health’s Monarch platform, a robotic-assisted bronchoscopy system that provides improved access and control.
Ethicon said the combined technologies offer “an exciting opportunity to catalyze new approaches and solutions to improve patient outcomes.”